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Tuberculous lymphadenitis (LAD) is the most 
common form of extrapulmonary tuberculosis (TB), 
accounting for 30 - 52% of cases of peripheral 
lymphadenopathy in developing countries with a 
high TB incidence.[1-3] In high-incidence countries, it 
is usually considered a disease of childhood,[4] while the peak age of 
tuberculous LAD in developed countries such as the USA has now 
been shown to be 30 - 40 years.[5]
In tuberculous LAD, fine needle aspiration biopsy (FNAB) has 
proved to be the diagnostic procedure of choice, with diagnostic yields 
varying from 42% to 83%, the highest yield in any extrapulmonary 
specimen investigation.[1,2,6] Although FNAB is simple, cost effective 
and safe, cytomorphology is not specific and microbiological cultures 
for speciation and drug sensitivity are required. The literature reports 
a variable detection rate of mycobacteria on cultures acquired by 
FNAB, with figures ranging between 35% and 83%.[1-3] In South Africa 
(SA), bacteriological confirmation defined as the identification of 
mycobacterial organisms, either by positive Ziehl-Neelsen stain, 
Papanicolaou autofluorescence and/or culture from aspirates in 
children is high, at 77.1%.[7] Comparative figures for aspirates in the 
adult population in SA are few and have small sample numbers.[8,9] 
With this background, a retrospective laboratory-based study 
was conducted to determine the bacteriological yield of clinically 
suspected mycobacterial LAD in adults, and specifically, HIV-positive 
patients, to determine the need for introduction of automated nucleic 
acid amplification tests (NAATs), such as the Xpert MTB/RIF assay as 
the initial diagnostic modality.
Methods
The study was conducted from May 2007 to March 2010 at the 
Tygerberg Hospital FNAB clinic. Ethical approval was received from 
the Stellenbosch University Health Research Ethics Committee (ref. 
no. S12/07/202). The study population included adults, ≥14 years 
of age (as defined in SA), referred to the FNAB clinic for suspected 
mycobacterial LAD, where cytomorphology was consistent with 
mycobacterial disease.
FNABs were performed by the trained sister or pathologist 
using a 23 G or 25 G needle attached to a 10  ml syringe. Two 
aspirates were performed, and the syringe rinsed in Mycobacterial 
Growth Indicator Tube (MGIT) medium for mycobacterial culture. 
Samples inoculated into MGIT were cultured according the standard 
operating procedure in the automated BACTEC MGIT 960 system 
(Becton Dickenson, USA). Cultures were incubated at 37°C for up to 
50 days or until flagged positive. 
A positive cytology diagnosis included cytomorphological features 
consistent with mycobacterial infection and confirmation of the 
organism on Ziehl-Neelsen stain or Papanicolaou autofluorescence. 
Results 
A total of 368 patients were included. Of these, 226 (61%) were 
HIV-positive, 25 (7%) HIV-negative and in 117 (32%) patients the 
HIV status was unknown. The numbers of women and men in the 
study population were 233 (63.3%) and 134 (36.4%), respectively. 
The gender of 1 (0.3%) patient was not recorded. Mycobacterial LAD 
(bacterial confirmation) was confirmed in 293 (79.6%) patients. Of 
these, 228 (77.8%) had positive MGIT cultures while in 65 (22%) 
cases with negative MGIT cultures, 64 (22%) were diagnosed on Ziehl 
Neelsen stain, and 1 (0.4%) on Papanicolaou autofluorescence. The 
average time to culture was 18.6 days (range 4 - 50). 
A significant difference was found between the diagnostic yield in 
the HIV-positive and -negative populations (84% v. 52%, respectively; 
p<0.001). The yield in the HIV-unknown population was 77%. Of 
the 228 positive cultures, 226 were Mycobacterium tuberculosis, 
1 M. avium-intracellulare, and 1 M. szulgai. The non-tuberculous 
organisms were both in HIV-positive patients. A positive culture 
for M. tuberculosis was obtained in 29/84 (34.5%) patients in whom 
a sputum sample had been submitted. The HIV status of 2 of these 
patients was unknown, while 27 patients were HIV-positive. 
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Background. Fine needle aspiration biopsy (FNAB) has been shown to be the diagnostic procedure of choice for superficial lymphadenitis 
in tuberculosis endemic regions. 
Methods. We conducted a retrospective laboratory-based study to determine the bacteriological yield of clinically suspected mycobacterial 
tuberculous lymphadenitis following FNAB in adults, and specifically HIV-positive patients, to determine the need for the introduction of 
automated nucleic acid amplification tests (NAATs) such as the Xpert MTB/RIF assay as the initial diagnostic modality.
Results. A diagnostic yield of 80% was achieved, significantly higher in HIV-positive v. HIV-negative patients (84% v. 52%, respectively; p<0.001). 
Conclusion. The results justify using automated NAATs such as the Xpert MTB/RIF assay as the initial diagnostic modality to expedite 
management in HIV-infected patients. 
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The mean age of patients diagnosed with 
mycobacterial LAD was 31.9 years (range 14 
- 71); with the mean age in the HIV-positive 
population being 32.6 years and in the HIV-
negative population 28.5 years.
Multivariate logistic regression analysis 
showed positive HIV status to be significantly 
associated with a positive bacteriological yield 
(p=0.005), independent of other variables 
included in the model, namely gender, age 
and site. The odds ratio indicates that an 
HIV-positive patient has 4.86 times higher 
odds of having a positive bacteriological yield 
(95% confidence interval 1.65 - 9.75) than an 
HIV-negative patient.
Discussion
The relationship between HIV and TB 
is bidirectional.[1,2] TB is a catalyst in the 
progression of HIV, and HIV infection is 
associated with an increased risk of developing 
TB. HIV alters the clinical presentation of 
TB such that TB progresses more rapidly 
and aggressively in HIV-infected individuals. 
Sputum smears, which are the cornerstone 
of diagnosis in resource-limited settings, 
are usually negative in HIV-associated TB, 
attested to by the 34.5% sputum culture yield 
in this study. This contributes to the diagnostic 
delay in treatment.[1,2] Extrapulmonary TB can 
occur either alone or in association with 
pulmonary TB in 40 - 60% of cases.[1,2] FNAB 
provides a means of easy access to diagnostic 
material in many of these pulmonary cases. 
This study shows that the bacteriological yield 
of FNAB in suspected mycobacterial LAD in 
adults is comparable to, and higher than, that 
found in children in TB-endemic areas. 
Compounding the problem of HIV and 
TB co-infection is immune reconstitution 
inflammatory syndrome (IRIS) where the 
initiation of antiretroviral treatment (ART) 
‘unmasks’ the clinically silent disease. [10] 
M. tuberculosis is estimated to account 
for about one-third of HIV-related IRIS 
events.[10] To avoid IRIS complications, 
ART is ideally initiated once mycobacterial 
infection has been excluded, but diagnosing 
TB using current diagnostic modalities has 
limitations. In this study, the average time 
to culture was excellent at 18.6 days, but 
this delay in initiating treatment increases 
the contagious risk, particularly in resistant 
disease. In endemic areas, patients with 
granulomatous inflammation are often 
treated empirically with anti-TB drugs, 
contributing to the generation of multidrug-
resistant TB. The heavy burden of TB, and 
HIV, in countries such as SA places a strain 
on scarce resources, which can be alleviated 
with a rapid diagnosis that reduces the 
number of follow-up visits.
Conclusion
Given the high diagnostic yield of 
mycobacterial LAD in HIV-infected adult 
patients on FNAB, and the pressure to 
expedite diagnosis, we feel this justifies 
recommending new automated NAATs such 
as the Xpert MTB/RIF test to be used as first-
line diagnostic modalities. The Xpert MTB/
RIF test has been shown to be of value in the 
diagnosis of extrapulmonary TB, including 
tuberculous LAD.[11,12] The advantages include 
minimal sample size, and ease and rapidity 
of diagnosis. The rapid turnaround time will, 
in turn, reduce the need for hospitalisation, 
reduce the contagious risk and decrease 
morbidity and mortality associated with the 
high TB burden in SA.
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Fig. 1. Study flow diagram. *Cytology = cytomorphology and identification of organism on Ziehl-
Neelsen stain or Papanicolaou autofluorescence.
